New obesity drug Mounjaro poised to surpass Ozempic, Wegovy - The Associated Press
- New obesity drug Mounjaro poised to surpass Ozempic, Wegovy The Associated Press
- Blood sugar drug tirzepatide also leads to substantial weight loss in diabetes patients, Eli Lilly says CNN
- Eli Lilly's tirzepatide passes 2nd weight loss trial with flying colors, gunning for FDA nod in 2023 FiercePharma
- View Full Coverage on Google News